Liposomal doxorubicin plus radiofrequency ablation for complete necrosis of a hepatocellular carcinoma. | Curr Oncol;20(3): e274-7, 2013 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Liposomal doxorubicin plus radiofrequency ablation for complete necrosis of a hepatocellular carcinoma.

Hong, C W; Libutti, S K; Wood, B J.

Affiliation

Hong CW; Center for Interventional Oncology, Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, MD, U.S.A. ; Lerner College of Medicine, Cleveland Clinic, Cleveland, OH, U.S.A.

Curr Oncol ; 20(3): e274-7, 2013 Jun.

Article in En | MEDLINE | ID: mdl-23737698

Key words

ablation; doxorubicin; hepatocellular carcinoma; liposomes; rfa

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Curr Oncol Year: 2013 Document type: Article Affiliation country: United States Country of publication: Switzerland

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Curr Oncol Year: 2013 Document type: Article Affiliation country: United States Country of publication: Switzerland